Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Neoplasms 13 Pancreatic Neoplasms 6 Breast Neoplasms 6 Ovarian Neoplasms 4 Uterine Cervical Neoplasms 3 Multiple Myeloma 3 Melanoma 3 Lymphoma 3 Thyroid Diseases 2 Prostatic Neoplasms 2 Pancreatic Cyst 2 Neoplasm Metastasis 2 Myasthenia Gravis 2 Mesothelioma, Malignant 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Hairy Cell 2 Leukemia 2 Hematologic Neoplasms 2 Endometrial Neoplasms 2 Wilms Tumor 1 Venous Thrombosis 1 Venous Thromboembolism 1 Uveal Melanoma 1 Uterine Cervical Dysplasia 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Thrombosis 1 Testicular Neoplasms 1

Interventions

Pemetrexed 22 Cisplatin 20 Nivolumab 8 Gemcitabine 7 Carboplatin 7 durvalumab 5 Ipilimumab 5 Bevacizumab 5 pembrolizumab 4 Radiotherapy, Intensity-Modulated 4 tremelimumab 3 niraparib 3 Oxaliplatin 3 Drug Therapy 3 Cyclophosphamide 3 Cerebral Decortication 3 Blood Specimen Collection 3 sargramostim 2 Thoracoscopy 2 Surveys and Questionnaires 2 Sorafenib 2 Radiosurgery 2 Magnesium Sulfate 2 Leucovorin 2 Imatinib Mesylate 2 Hyperthermic Intraperitoneal Chemotherapy 2 Doxorubicin 2 Dexamethasone 2 tislelizumab 1 spartalizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Mesothelioma × Data Collection × Clear all

NCT05308966 2025-10-06

MESO-IMMUNE

Groupe Francais De Pneumo-Cancerologie

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡